Purpose: A novel grid-template-mimicking MR-compatible robot was developed for in-gantry MRI-guided focal laser ablation of prostate cancer. Method: A substantially compact robot was designed and prototyped to meet in-gantry lithotomy ergonomics and allow for accommodation in the perineum. The controller software was reconfigured and integrated with the custom-designed navigation and multi-focal ablation software. Three experiments were conducted: (1) free space accuracy test; (2) phantom study under computed tomography (CT) guidance for image-guided accuracy test and overall workflow; and (3) magnetic resonance imaging (MRI)-guided focal laser ablation of an ex vivo prostate. The free space accuracy study included five targets that were selected across the workspace. The robot was then commanded five times to each target. The phantom study used a gel phantom made with color changing thermos-chromic ink, and four spherical metal fiducials were deployed with the robot. Then, laser ablation was applied, and the phantom was sliced for gross observation. For an MR-guided ex vivo test, a prostate from a donor who died of prostate cancer was obtained and multi-focally ablated using the system within the MRI gantry. The tissue was sliced after ablation for validation. Results: free-space accuracy was 0.38 ± 0.27 mm. The overall system targeting accuracy under CT guidance (including robot, registration, and insertion error) was 2.17 ± 0.47 mm. The planned ablation zone was successfully covered in both acrylamide gel phantom and in human prostate tissue. Conclusions: The new robot can accurately facilitate fiber targeting for MR-guided focal laser ablation of targetable prostate cancer.
Purpose: This study aims to investigate the accuracy of a cross platform augmented reality (AR) system for percutaneous needle interventions irrespective of operator error. In particular, we study the effect of the relative position and orientation of the AR device and the marker, the location of the target, and the angle of needle on the overlay accuracy. Method: A needle guidance AR platform developed using Unity and Vuforia SDK platforms was used to display a planned needle trajectory for targets via mobile and wearable devices. To evaluate the system accuracy, a custom phantom embedded with metal fiducial markers and an adjustable needle guide was designed to mimic different relative position and orientation scenarios of the smart device and the marker. After segmenting images of CT-visible fiducial markers as well as different needle trajectories, error was defined by comparing them to the corresponding augmented target/needle trajectory projected by smartphone and smartglasses devices. Results: The augmentation error for targets and needle trajectories were reported as a function of marker position and orientation, as well as the location of the targets. Overall, the image overlay error for needle trajectory was 0.28±0.32° (Max = 0.856°) and 0.41±0.23° (Max = 0.805°) using the iPhone and HoloLens glasses, respectively. The overall image overlay error for targets was 1.75±0.59 mm for iPhone, and 1.74±0.86 mm for HoloLens. Conclusions: The image overlay error caused by different sources can be quantified for different AR devices.
21 May 2021 in CardioVascular and Interventional Radiology